Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Validation of the INNO-LiPA HBV DR Assay (Version 2) in Monitoring Hepatitis B Virus-Infected Patients Receiving Nucleoside Analog Treatment, Antimicrobial Agents and Chemotherapy, January 2010, ASM Journals, DOI: 10.1128/aac.00970-09.
You can read the full text:
Be the first to contribute to this page